Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
3.800
+0.070 (1.88%)
At close: Jul 18, 2025, 4:00 PM
3.780
-0.020 (-0.53%)
After-hours: Jul 18, 2025, 6:20 PM EDT
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $3.38M in the quarter ending March 31, 2025, a decrease of -10.14%. This brings the company's revenue in the last twelve months to $17.54M, down -2.06% year-over-year. In the year 2024, Ekso Bionics Holdings had annual revenue of $17.93M, down -1.94%.
Revenue (ttm)
$17.54M
Revenue Growth
-2.06%
P/S Ratio
0.32
Revenue / Employee
$265,818
Employees
66
Market Cap
7.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EKSO News
- 1 day ago - Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country - GlobeNewsWire
- 4 weeks ago - Ekso Bionics' Acceptance into NVIDIA Connect Program Bears Early Fruit - GlobeNewsWire
- 2 months ago - Ekso Bionics Announces New Effective Date of Reverse Stock Split - GlobeNewsWire
- 2 months ago - Ekso Bionics Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - Ekso Bionics Accepted into NVIDIA Connect Program - GlobeNewsWire
- 2 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ekso Bionics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow - GlobeNewsWire